NCT03409627 - Novel INXN-4001 Triple Effector Plasmid in Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

March 4, 2020

Study Completion Date

August 12, 2020

Conditions

Heart FailureCardiovascular DiseasesHeart-Assist Device

Interventions

BIOLOGICAL

INXN-4001

Retrograde coronary sinus infusion of triple effector plasmid (INXN-4001)

Trial Locations (2)

The Lindner Research Center, The Christ Hospital Health Network, Cincinnati

University of Arizona Sarver Heart Center, Tucson